April 2018

New Product - Alprolix

Alprolix (eftrenonacog alfa (rhu)) is a long acting, fully recombinant fusion protein consisting of human coagulation factor IX (FIX) covalently linked to the Fc domain of human IgG1. Alprolix is indicated in adults and children with haemophilia B (congenital factor IX deficiency) for: control and prevention of bleeding episodes; routine prophylaxis to prevent or reduce the frequency of bleeding episodes; perioperative management (surgical prophylaxis). Alprolix is available in single vials containing 250 IU, 500 IU, 1000 IU, 2000 IU and 3000 IU.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au